5-heteroaryl thiazoles and their use as P13K inhibitors

Details for Australian Patent Application No. 2005303566 (hide)

Owner AstraZeneca AB

Inventors Griffen, Edward Jolyon; Bailey, John Peter; Bengtsson, Malena; Bird, Thomas Geoffrey Colerick; Nikitidis, Grigorios; Storm, Peter; Arnould, JeanClaude; Larsson, Joakim

Agent Davies Collison Cave

Pub. Number AU-A-2005303566

PCT Pub. Number WO2006/051270

Priority 0402735-5 09.11.04 SE

Filing date 7 November 2005

Wipo publication date 18 May 2006

International Classifications

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/4439 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/051270 Priority application(s): WO2006/051270

9 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005303576-Rotary valve

2005303565-Treatment of acne using derivatives of 5-aminolevulinic acid